• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids.

作者信息

Seifert H, Perrin M, Rivier J, Vale W

出版信息

Endocrinology. 1985 Jul;117(1):424-6. doi: 10.1210/endo-117-1-424.

DOI:10.1210/endo-117-1-424
PMID:2988927
Abstract

Specific high affinity binding sites for growth hormone releasing factor (GRF) were described in rat anterior pituitary homogenates with use of the analog [His1-mono-125I-Tyr10,Nle27]-hGRF(1-32)-NH2 as radioligand. Computerized analysis of competition experiments indicated one class of specific high affinity binding sites with a dissociation constant of 0.19 nM. The relative binding affinities of rGRF, hGRF(1-40) and various analogs correlated well with their in vitro biological potencies. Further, the number binding sites was drastically decreased after adrenalectomy; chronic dexamethasone treatment of these animals restored GRF binding capacity to control without changing binding affinity. These results may in part explain the enhanced responsiveness of the somatotroph after dexamethasone treatment.

摘要

相似文献

1
Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids.
Endocrinology. 1985 Jul;117(1):424-6. doi: 10.1210/endo-117-1-424.
2
Binding sites for growth hormone releasing factor on rat anterior pituitary cells.生长激素释放因子在大鼠垂体前叶细胞上的结合位点
Nature. 1985;313(6002):487-9. doi: 10.1038/313487a0.
3
Desensitization to growth hormone-releasing factor (GRF) is associated with down-regulation of GRF-binding sites.对生长激素释放因子(GRF)的脱敏作用与GRF结合位点的下调有关。
Endocrinology. 1986 May;118(5):2045-52. doi: 10.1210/endo-118-5-2045.
4
Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.利用大鼠和人的生长激素释放因子(GRF)及肠血管活性肠肽(VIP)受体研究GRF与VIP受体相互作用的物种特异性:有证据表明,Ac-Tyr1hGRF在大鼠中是一种竞争性VIP拮抗剂。
Mol Pharmacol. 1986 Jan;29(1):23-7.
5
Identification of receptor-binding pharmacophores of growth-hormone-releasing factor in rat adenopituitary.
Neuroendocrinology. 1994 Apr;59(4):363-70. doi: 10.1159/000126679.
6
Characterization of [125I-Tyr10]human growth hormone-releasing factor (1-44) amide binding to rat pituitary: evidence for high and low affinity classes of sites.
Brain Res. 1990 Oct 1;528(2):291-9. doi: 10.1016/0006-8993(90)91670-c.
7
Effect of lead on TRH and GRF binding in rat anterior pituitary membranes.
Toxicology. 1991;68(2):169-79. doi: 10.1016/0300-483x(91)90019-w.
8
Specific binding of synthetic human pancreatic growth hormone releasing factor (1-40-OH) to bovine anterior pituitaries.合成人胰腺生长激素释放因子(1-40-OH)与牛垂体前叶的特异性结合。
Biochem Biophys Res Commun. 1985 Jan 16;126(1):33-9. doi: 10.1016/0006-291x(85)90567-4.
9
Nucleotide regulation of growth hormone-releasing factor binding to rat pituitary receptors.核苷酸对生长激素释放因子与大鼠垂体受体结合的调节作用。
Endocrinology. 1989 Jan;124(1):24-9. doi: 10.1210/endo-124-1-24.
10
Use of radioreceptor assay and cell superfusion system for in vitro screening of analogs of growth hormone-releasing hormone.利用放射受体分析法和细胞灌流系统对生长激素释放激素类似物进行体外筛选。
Receptor. 1993 Summer;3(2):87-97.

引用本文的文献

1
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond.生长激素/胰岛素样生长因子-1轴的中枢和外周调节:生长激素释放激素及其他相关因素
Rev Endocr Metab Disord. 2024 Nov 23. doi: 10.1007/s11154-024-09933-6.
2
Dexamethasone Stimulation Test in the Diagnostic Work-Up of Growth Hormone Deficiency in Childhood: Clinical Value and Comparison With Insulin-Induced Hypoglycemia.地塞米松刺激试验在儿童生长激素缺乏症诊断中的应用:临床价值及与胰岛素诱导低血糖试验的比较。
Front Endocrinol (Lausanne). 2020 Dec 9;11:599302. doi: 10.3389/fendo.2020.599302. eCollection 2020.
3
Glucocorticoids and the regulation of growth hormone secretion.
糖皮质激素与生长激素分泌的调节。
Nat Rev Endocrinol. 2013 May;9(5):265-76. doi: 10.1038/nrendo.2013.5. Epub 2013 Feb 5.
4
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.分泌生长激素释放激素的神经内分泌肿瘤:病理生理与临床方面
Pituitary. 2006;9(3):221-9. doi: 10.1007/s11102-006-0267-0.
5
Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity.原发性肾上腺皮质功能减退症患者的生长激素(GH)分泌:皮质醇撤药及模式化替代治疗对GH脉冲性分泌和昼夜节律的影响
Pituitary. 2000 Nov;3(3):175-9. doi: 10.1023/a:1011455826842.
6
Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization.生长激素释放激素受体mRNA在非肿瘤性垂体及垂体腺瘤中的意义:一项逆转录聚合酶链反应和原位杂交研究
J Neurooncol. 1999 Feb;41(3):197-204. doi: 10.1023/a:1006151001536.
7
Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.肢端肥大症垂体瘤中的生长激素释放激素受体信使核糖核酸
Am J Pathol. 1997 Jun;150(6):1885-91.
8
Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.人类生长激素分泌的神经内分泌调节。诊断及临床应用。
J Endocrinol Invest. 1988 Jun;11(6):441-62. doi: 10.1007/BF03349081.